These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6809840)

  • 1. Activation of components of the alternative pathway of complement by Propionibacterium acnes cell wall carbohydrate.
    Webster GF; McArthur WP
    J Invest Dermatol; 1982 Sep; 79(3):137-40. PubMed ID: 6809840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions.
    Webster GF; Nilsson UR; McArthur WP
    Inflammation; 1981 Jun; 5(2):165-76. PubMed ID: 7275277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural hemolytic and bactericidal activities of sea bream Sparus aurata serum are effected by the alternative complement pathway.
    Sunyer JO; Tort L
    Vet Immunol Immunopathol; 1995 Apr; 45(3-4):333-45. PubMed ID: 7676614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolysis by the complement of tanned erythrocytes coated with cobra venom factor: a sensitive method to detect the alternative complement pathway activity of serum.
    Okada H; Tanaka H
    J Immunol Methods; 1981; 46(1):85-95. PubMed ID: 6793665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum.
    Webster GF; Leyden JJ; Norman ME; Nilsson UR
    Infect Immun; 1978 Nov; 22(2):523-9. PubMed ID: 153333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quantitation of alternative pathway complement function by timed lysis assay.
    Jones BM
    J Immunol Methods; 1979; 29(3):287-92. PubMed ID: 114593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody titers to Propionibacterium acnes cell wall carbohydrate in nodulocystic acne patients.
    Webster GF; Indrisano JP; Leyden JJ
    J Invest Dermatol; 1985 Jun; 84(6):496-500. PubMed ID: 3158714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.
    Hidvégi T; Füst G; Rajnavölgyi E; Kulics J; Gergely J
    Immunology; 1985 Dec; 56(4):735-41. PubMed ID: 3935572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in carbohydrate specificities and complement-activating capacity of guinea pig and human antibodies to neuraminidase-treated autologous erythrocytes.
    Lambré CR; Pilatte Y; Le Maho S; Blanc C
    Mol Immunol; 1985 Sep; 22(9):1123-9. PubMed ID: 2415814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equine alternative pathway activation by unsensitized rabbit red blood cells.
    Leid RW; Coley SC; Blanchard DP; Perryman LE
    Vet Immunol Immunopathol; 1985 May; 9(1):71-85. PubMed ID: 4024451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in acne vulgaris: consumption of complement by comedones.
    Webster GF; Leyden JJ; Nilsson UR
    Infect Immun; 1979 Oct; 26(1):183-6. PubMed ID: 159261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple alternative pathway for hemolytic assay of human complement component C3 using methylamine-treated plasma.
    Jessen TE; Barkholt V; Welinder KG
    J Immunol Methods; 1983 May; 60(1-2):89-100. PubMed ID: 6406606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sheep serum complement sensitisation of sheep erythrocyte-rabbit antibody complexes for haemolysis by guinea-pig complement plus EDTA or Mg2+-EGTA.
    Jonas W; Stankiewicz M
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):451-60. PubMed ID: 3099725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of Brucella abortus lipopolysaccharide (LPS) to activate the alternative pathway of complement.
    Hoffmann EM; Houle JJ
    Vet Immunol Immunopathol; 1983 Nov; 5(1):65-76. PubMed ID: 6419447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the alternative pathway of complement by antiserum to factor B.
    Wilson MR; Arroyave CM; Tan EM
    J Lab Clin Med; 1979 Mar; 93(3):493-8. PubMed ID: 107255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the sensitivity of erythrocytes to lysis by heterologous sera via the alternative complement pathway.
    Van Dijk H; Heezius E; Van Kooten PJ; Rademaker PM; Van Dam R; Willers JM
    Vet Immunol Immunopathol; 1983 May; 4(4):469-77. PubMed ID: 6868341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative pathway activation of complement in fetal lamb serum by Trichostrongylus vitrinus larvae.
    Stankiewicz M; Jonas W; Elliott D
    Parasite Immunol; 1981; 3(4):309-18. PubMed ID: 6798533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the alternative pathway of human complement by haemoglobin.
    Wilson WA; Thomas EJ
    Clin Exp Immunol; 1979 Apr; 36(1):140-4. PubMed ID: 111881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.